Ortuvo, founded in 2020 and headquartered in Baltimore, Maryland, is a pioneering software company specializing in the development of 3D printing research tools and custom bio-inks for the healthcare and biotech industries. The company's core mission is to advance tissue engineering through innovative in vitro research tools that are both novel and scalable. By leveraging proprietary technology, Ortuvo aims to enhance the capabilities of researchers and clinicians in creating more effective and personalized medical treatments.
Notable figures affiliated with Ortuvo include Erin Lavik, PhD, Stephen Farias, PhD, Ken Malone, PhD, and Kelli Booth Scott, who collectively bring extensive expertise in science and engineering. The company has garnered attention for its cutting-edge contributions to tissue engineering and has made significant strides in developing scalable solutions for the biotech sector. Ortuvo's impact is evident in its ability to provide advanced tools that facilitate groundbreaking research, positioning it as a key player in the intersection of technology and healthcare.
